Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 2;110(21):3513-3533.
doi: 10.1016/j.neuron.2022.10.015.

Microglial efferocytosis: Diving into the Alzheimer's disease gene pool

Affiliations
Free article
Review

Microglial efferocytosis: Diving into the Alzheimer's disease gene pool

Carmen Romero-Molina et al. Neuron. .
Free article

Abstract

Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer's disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches.

Keywords: Alzheimer’s disease; cholesterol metabolism; efferocytosis; endolysosomal system; functional genomics; gene expression regulation; human genetics; immunometabolism; innate immune response; microglia; phagocytosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.M.G. is on the scientific advisory boards for Genentech and Muna Therapeutics. A.M.G. is a member of the advisory board for the Cell Press Journal Med. A.M.G. has served as a consultant for AbbVie.

Similar articles

Cited by

Publication types

LinkOut - more resources